The Oncology Care Model: Implications for Cancer Care Delivery and Payment Reform
Cancer care is very expensive, and the cost is rising at an unsustainable rate. The Centers for Medicare & Medicaid Services (CMS) reported that medical expenditures related to cancer are expected to stretch to $158 billion in the year 2020. Cancer patients receiving systemic therapy represent the group with the highest costs. The Oncology Care Model is the largest medical subspecialty alternative payment model developed and administered by the Center for Medicare and Medicaid Innovation. This pilot program, launched in July 2016, aims to improve the delivery of cancer care while controlling costs by holding providers responsible for the total cost of care. Many of the changes in care delivery required to succeed in this program involve fundamental practice transformation. In this webinar, Dr. Michael Kolodziej will discuss the rationale for this model, results to date, as well as a forecast for the ultimate results of the model. He will also project the next stage of cancer care payment reform.
What: Alliance to Advance Patient Centered Cancer Care Webinar – The Oncology Care Model: Implications for Cancer Care Delivery and Payment Reform
When: Thursday, April 11th 2:00 PM – 3:00 PM EST
Register by: Tuesday, April 9th, 2019
Cost: The webinar is free for all attendees
Michael Kolodziej, MD
Vice President and Chief Innovation Officer
ADVI Health
Dr. Kolodziej is vice president and chief innovation officer for ADVI Health. He received his undergraduate and medical degrees from Washington University in St. Louis where he was Phi Beta Kappa and Alpha Omega Alpha. He completed internal medicine and hematology-oncology training at the University of Pennsylvania in Philadelphia.
He was an associate professor the University of Oklahoma School of Medicine, then joined New York Oncology and was a partner in the practice until December 2012. He was an active member of the US Oncology Pharmacy and Therapeutics committee, serving on the executive committee and as chair. He served as medical director for oncology services for US Oncology from 2007-2011, where he helped direct the implementation of the USON clinical pathways initiative, the integration of the USON EMR into this program, and the development of the USON disease management and advanced care planning programs, now known as Innovent Oncology. He joined Aetna in 2013 as national medical director, Oncology Solutions, where he directed Aetna’s oncology delivery reform pilots and was architect of the Aetna Oncology Medical Home program. He was active in Aetna’s pharmacy policy, condition analysis and genetics subcommittees.
Dr. Kolodziej joined Flatiron Health in 2016 as national medical director, Managed Care Strategy, where he applied the core tech and data capabilities of Flatiron to facilitate practice transformation and success in alternative payment models. He joined ADVI in October 2017. He is a Fellow of the American College of Physicians. He has published and spoken extensively on payment reform, personalized medicine and practice care delivery transformation in oncology.